240 related articles for article (PubMed ID: 28630090)
1. T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.
Hosokawa K; Kajigaya S; Keyvanfar K; Qiao W; Xie Y; Townsley DM; Feng X; Young NS
J Immunol; 2017 Jul; 199(2):477-488. PubMed ID: 28630090
[TBL] [Abstract][Full Text] [Related]
2. [Quantity and function of T cell subsets in patients with paroxysmal nocturnal hemoglobinuria].
Zhang T; Liang Y; Fu R; Li LJ; Wang J; Liu H; Wang HL; Ruan EB; Qu W; Wang GJ; Wu YH; Liu H; Wang HQ; Wang XM; Song J; Guan J; Xing LM; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):721-5. PubMed ID: 20561437
[TBL] [Abstract][Full Text] [Related]
3. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
4. Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria.
Gargiulo L; Papaioannou M; Sica M; Talini G; Chaidos A; Richichi B; Nikolaev AV; Nativi C; Layton M; de la Fuente J; Roberts I; Luzzatto L; Notaro R; Karadimitris A
Blood; 2013 Apr; 121(14):2753-61. PubMed ID: 23372165
[TBL] [Abstract][Full Text] [Related]
5. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
6. T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway.
Terrazzano G; Sica M; Becchimanzi C; Costantini S; Rotoli B; Zappacosta S; Alfinito F; Ruggiero G
J Leukoc Biol; 2005 Jul; 78(1):27-36. PubMed ID: 15817705
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells.
Chen G; Zeng W; Maciejewski JP; Kcyvanfar K; Billings EM; Young NS
Leukemia; 2005 May; 19(5):862-8. PubMed ID: 15759038
[TBL] [Abstract][Full Text] [Related]
8. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
Shichishima T
Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
[TBL] [Abstract][Full Text] [Related]
9. Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria.
Karadimitris A; Manavalan JS; Thaler HT; Notaro R; Araten DJ; Nafa K; Roberts IA; Weksler ME; Luzzatto L
Blood; 2000 Oct; 96(7):2613-20. PubMed ID: 11001919
[TBL] [Abstract][Full Text] [Related]
10. [Paroxysmal nocturnal hemoglobinuria].
Peffault de Latour R; Amoura Z; Socié G
Rev Med Interne; 2010 Mar; 31(3):200-7. PubMed ID: 19303177
[TBL] [Abstract][Full Text] [Related]
11. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
12. Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability.
Chen G; Zeng W; Green S; Young NS
Br J Haematol; 2004 May; 125(3):383-91. PubMed ID: 15086421
[TBL] [Abstract][Full Text] [Related]
13. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of paroxysmal nocturnal hemoglobinuria.
Parker CJ
Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
Bessler M
Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
[TBL] [Abstract][Full Text] [Related]
16. Paroxysmal nocturnal hemoglobinuria (membrane defect, pathogenesis, aplastic anemia, diagnosis).
Chrobák L
Acta Medica (Hradec Kralove); 2000; 43(1):3-8. PubMed ID: 10934778
[TBL] [Abstract][Full Text] [Related]
17. Minor populations of paroxysmal nocturnal hemoglobinuria-type cells in patients with chronic idiopathic neutropenia.
Damianaki A; Stagakis E; Mavroudi I; Spanoudakis M; Koutala H; Papadogiannis F; Kanellou P; Pontikoglou C; Papadaki HA
Eur J Haematol; 2016 Dec; 97(6):538-546. PubMed ID: 27124520
[TBL] [Abstract][Full Text] [Related]
18. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
Kawaguchi T; Nakakuma H
Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.
Shichishima T; Noji H
Int J Hematol; 2006 Aug; 84(2):97-103. PubMed ID: 16926129
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.
Meletis J; Terpos E
Med Sci Monit; 2003 Jul; 9(7):RA161-72. PubMed ID: 12883466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
